Clinical Trial Detail

NCT ID NCT03537599
Title Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sumithira Vasu
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Daratumumab

Age Groups: adult child senior

No variant requirements are available.